Peter Salgo, MD, and John L. Fox, MD, MHA, discuss the definition of predictive value of diagnostic testing in cancer and describe the value of the genomic assays that are currently available in ...

Traditional testing, though valuable, is often reactive and identifies quality issues only after they have occurred. This can lead to project delays and financial and reputational losses. In fact, ...

CYP2D6 polymorphism in Chinese breast cancer population. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a full text component.

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.